• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成 MRI 在预测雌激素受体阳性乳腺癌 Ki-67 状态中的应用:一项可行性研究。

Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: a feasibility study.

机构信息

Department of Radiology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.

Department of Radiology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.

出版信息

Clin Radiol. 2020 May;75(5):398.e1-398.e8. doi: 10.1016/j.crad.2019.12.021. Epub 2020 Feb 1.

DOI:10.1016/j.crad.2019.12.021
PMID:32019671
Abstract

AIM

To evaluate the utility of synthetic magnetic resonance imaging (MRI) of the breast in predicting the Ki-67 status in patients with oestrogen receptor (ER)-positive breast cancer.

MATERIALS AND METHODS

Forty-nine patients with 50 histopathologically proven breast cancers who underwent additional synthetic MRI were enrolled in the present study. Using synthetic MRI images, T1 and T2 relaxation times and their standard deviations (SD) in the breast lesions before (T1-Pre, T2-Pre, PD-Pre, SD of T1-Pre, SD of T2-Pre, SD of PD-Pre) and after (T1-Gd, T2-Gd, PD-Gd, SD of T1-Gd, SD of T2-Gd, SD of PD-Gd) contrast agent injection were obtained. These quantitative values were compared between the low Ki-67 expression (<14%) lesions (low-proliferation group: n=23) and high Ki-67 expression (≥14%) lesions (high-proliferation group: n=27).

RESULTS

The univariate analysis showed that the SD of T1-Gd (p<0.001) and T2-Gd (p=0.042) were significantly higher in the high-proliferation group than in the low-proliferation group. Multivariate analysis further showed that the SD of T1-Gd was a significant and independent predictor of Ki-67 expression, with an area under the receiver operating characteristic (AUROC) curve of 0.885. The sensitivity, specificity, and accuracy of the SD of T1-Gd with an optimal cut-off value of 98.5 were 77.8%, 87%, and 82%, respectively.

CONCLUSION

The SD of T1-Gd obtained from synthetic MRI was useful to predict Ki-67 status.

摘要

目的

评估合成磁共振成像(MRI)在预测雌激素受体(ER)阳性乳腺癌患者 Ki-67 状态中的作用。

材料和方法

本研究纳入了 49 例经组织学证实的 50 例乳腺病变患者,这些患者均接受了额外的合成 MRI 检查。使用合成 MRI 图像,获得了病变区 T1 和 T2 弛豫时间及其在对比剂注射前后的标准差(T1-Pre、T2-Pre、PD-Pre、T1-Pre 的 SD、T2-Pre 的 SD、PD-Pre 的 SD),并比较了低 Ki-67 表达(<14%)病变(低增殖组:n=23)和高 Ki-67 表达(≥14%)病变(高增殖组:n=27)之间的这些定量值。

结果

单因素分析显示,高增殖组 T1-Gd(p<0.001)和 T2-Gd(p=0.042)的 SD 明显高于低增殖组。多因素分析进一步表明,T1-Gd 的 SD 是 Ki-67 表达的一个显著独立预测因子,其受试者工作特征(ROC)曲线下面积(AUROC)为 0.885。当 T1-Gd 的 SD 的最佳截断值为 98.5 时,其灵敏度、特异度和准确度分别为 77.8%、87%和 82%。

结论

合成 MRI 获得的 T1-Gd 的 SD 有助于预测 Ki-67 状态。

相似文献

1
Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: a feasibility study.合成 MRI 在预测雌激素受体阳性乳腺癌 Ki-67 状态中的应用:一项可行性研究。
Clin Radiol. 2020 May;75(5):398.e1-398.e8. doi: 10.1016/j.crad.2019.12.021. Epub 2020 Feb 1.
2
Utility of synthetic MRI in predicting pathological complete response of various breast cancer subtypes prior to neoadjuvant chemotherapy.合成 MRI 在新辅助化疗前预测各种乳腺癌亚型病理完全缓解的效用。
Clin Radiol. 2022 Nov;77(11):855-863. doi: 10.1016/j.crad.2022.06.019. Epub 2022 Aug 30.
3
Triple-negative breast cancer on contrast-enhanced MRI and synthetic MRI: A comparison with non-triple-negative breast carcinoma.对比增强磁共振成像和合成磁共振成像上的三阴性乳腺癌:与非三阴性乳腺癌的比较。
Eur J Radiol. 2021 Sep;142:109838. doi: 10.1016/j.ejrad.2021.109838. Epub 2021 Jun 28.
4
Investigation of synthetic MRI with quantitative parameters for discriminating axillary lymph nodes status in invasive breast cancer.采用合成 MRI 及定量参数对浸润性乳腺癌腋窝淋巴结状态进行鉴别诊断的研究。
Eur J Radiol. 2024 Jun;175:111452. doi: 10.1016/j.ejrad.2024.111452. Epub 2024 Apr 4.
5
DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.基于肿瘤亚区划分的 DCE-MRI 纹理分析预测雌激素受体阳性乳腺癌的 Ki-67 状态。
J Magn Reson Imaging. 2018 Jul;48(1):237-247. doi: 10.1002/jmri.25921. Epub 2017 Dec 8.
6
Differences in tumour heterogeneity based on dynamic contrast-enhanced MRI between tumour and peritumoural stroma for predicting Ki-67 status of invasive ductal carcinoma.基于肿瘤和肿瘤周围基质的动态对比增强 MRI 的肿瘤异质性差异预测浸润性导管癌的 Ki-67 状态。
Clin Radiol. 2021 Jun;76(6):470.e13-470.e22. doi: 10.1016/j.crad.2020.12.008. Epub 2021 Feb 26.
7
Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.雌激素受体阳性浸润性乳腺癌的动态对比增强和扩散加权磁共振成像:磁共振定量参数与Ki-67增殖状态之间的关联。
J Magn Reson Imaging. 2017 Jan;45(1):94-102. doi: 10.1002/jmri.25348. Epub 2016 Jun 17.
8
Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status.乳腺癌的合成磁共振成像:鉴别良恶性病变及预测免疫组化表达状态。
Sci Rep. 2023 Oct 20;13(1):17978. doi: 10.1038/s41598-023-45079-2.
9
Synthetic MRI with quantitative mappings for identifying receptor status, proliferation rate, and molecular subtypes of breast cancer.基于定量图谱的合成 MRI 用于识别乳腺癌的受体状态、增殖率和分子亚型。
Eur J Radiol. 2022 Mar;148:110168. doi: 10.1016/j.ejrad.2022.110168. Epub 2022 Jan 20.
10
An MRI-based Radiomics Classifier for Preoperative Prediction of Ki-67 Status in Breast Cancer.基于 MRI 的放射组学分类器用于术前预测乳腺癌 Ki-67 状态。
Acad Radiol. 2018 Sep;25(9):1111-1117. doi: 10.1016/j.acra.2018.01.006. Epub 2018 Feb 7.

引用本文的文献

1
B1 corrected T1 mapping in the differentiation and prediction of breast cancer.B1校正T1映射在乳腺癌的鉴别诊断和预测中的应用
Sci Rep. 2025 Aug 21;15(1):30785. doi: 10.1038/s41598-025-15590-9.
2
Understanding cellular proliferation activity in breast cancer using multi-compartment model of transverse relaxation time mapping on 3T MRI.利用3T磁共振成像横向弛豫时间映射的多室模型理解乳腺癌中的细胞增殖活性。
Front Oncol. 2025 Jan 30;15:1482112. doi: 10.3389/fonc.2025.1482112. eCollection 2025.
3
Quantitative evaluation of meniscus injury using synthetic magnetic resonance imaging.
采用合成磁共振成像技术对半月板损伤进行定量评估。
BMC Musculoskelet Disord. 2024 Apr 15;25(1):292. doi: 10.1186/s12891-024-07375-4.
4
Multiparametric MRI model with synthetic MRI, DWI multi-quantitative parameters, and differential sub-sampling with cartesian ordering enables BI-RADS 4 lesions diagnosis with high accuracy.具有合成MRI、DWI多定量参数以及笛卡尔排序差分子采样的多参数MRI模型能够高精度诊断BI-RADS 4类病变。
Front Oncol. 2024 Jan 5;13:1180131. doi: 10.3389/fonc.2023.1180131. eCollection 2023.
5
Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status.乳腺癌的合成磁共振成像:鉴别良恶性病变及预测免疫组化表达状态。
Sci Rep. 2023 Oct 20;13(1):17978. doi: 10.1038/s41598-023-45079-2.
6
A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.基于合成 MRI 采集的放射组学模型预测三阴性乳腺癌新辅助全身治疗反应
Radiol Imaging Cancer. 2023 Jul;5(4):e230009. doi: 10.1148/rycan.230009.
7
Predicting of Ki-67 Expression Level Using Diffusion-Weighted and Synthetic Magnetic Resonance Imaging in Invasive Ductal Breast Cancer.基于扩散加权成像和磁共振合成图像预测浸润性导管乳腺癌的 Ki-67 表达水平。
Breast J. 2023 Apr 5;2023:6746326. doi: 10.1155/2023/6746326. eCollection 2023.
8
Quantitative Values from Synthetic MRI Correlate with Breast Cancer Subtypes.合成磁共振成像的定量值与乳腺癌亚型相关。
Life (Basel). 2022 Aug 25;12(9):1307. doi: 10.3390/life12091307.
9
Diagnostic performance of synthetic magnetic resonance imaging in the prognostic evaluation of rectal cancer.合成磁共振成像在直肠癌预后评估中的诊断性能
Quant Imaging Med Surg. 2022 Jul;12(7):3580-3591. doi: 10.21037/qims-22-24.
10
Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review.乳腺癌亚型与定量磁共振成像:一项系统综述
Life (Basel). 2022 Mar 28;12(4):490. doi: 10.3390/life12040490.